RPG Life Sciences hits record high, zooms 51% so far in September

The domestic formulations business of the company will continue to focus on building chronic therapies, expanding specialty portfolio and life cycle management of current legacy products

Shares of RPG Life Sciences continued at their northward movement, hitting a fresh record high of Rs 751.80, up 8 per cent on the BSE in intra-day trade on Tuesday. So far in the month of September, the stock of the pharmaceutical company has zoomed 51 per cent on expectation of a promising outlook for the domestic formulation industry.

RPG Life Science is exclusively engaged in the pharmaceutical business and operates across domestic formulations, international formulations and active pharmaceutical ingredients (API).

In the April-June quarter (Q1FY22), the overall performance of the company continued to be strong despite the impact of the second